Jane Street
RNAC icon

Jane Street’s Cartesian Therapeutics RNAC Stock Holding History

Jane Street’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123K Buy
+11,824
New +$87.6K ﹤0.01% 10484
2024
Q2 		– Sell
-6,340
Closed -$124K – 10067
2024
Q1 		$124K Buy
6,340
+3,483
+122% +$73.8K ﹤0.01% 8444
2023
Q4 		$59.1K Buy
+2,857
New +$85.3K ﹤0.01% 8743
2023
Q3 		– Sell
-520
Closed -$17.5K – 9266
2023
Q2 		$17.5K Sell
520
-5,481
-91% -$196K ﹤0.01% 8372
2023
Q1 		$250K Buy
+6,001
New +$282K ﹤0.01% 7479
2022
Q4 		– Sell
-1,274
Closed -$63K – 9993
2022
Q3 		$63K Buy
1,274
+161
+14% +$8.84K ﹤0.01% 8840
2022
Q2 		$44K Buy
1,113
+738
+197% +$21.9K ﹤0.01% 8964
2022
Q1 		$14K Sell
375
-2,365
-86% -$148K ﹤0.01% 10019
2021
Q4 		$268K Buy
2,740
+2,338
+582% +$252K ﹤0.01% 8379
2021
Q3 		$50K Sell
402
-412
-51% -$49.8K ﹤0.01% 9549
2021
Q2 		$102K Buy
+814
New +$96.9K ﹤0.01% 9249
2021
Q1 		– Sell
-463
Closed -$42K – 9511
2020
Q4 		$42K Sell
463
-229
-33% -$19.9K ﹤0.01% 7335
2020
Q3 		$51K Sell
692
-4,924
-88% -$377K ﹤0.01% 6912
2020
Q2 		$478K Buy
5,616
+2,114
+60% +$192K ﹤0.01% 5153
2020
Q1 		$253K Buy
+3,502
New +$338K ﹤0.01% 4401
2019
Q3 		– Sell
-3,632
Closed -$195K – 5647
2019
Q2 		$195K Buy
+3,632
New +$248K ﹤0.01% 4700

Other funds holding RNAC

Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street's RNAC Position: Q2 2026 in Review

Jane Street opened a new position in Cartesian Therapeutics (RNAC) in Q2 2026: 11,824 shares worth $123K. The stake represents ﹤0.01% of the portfolio and ranks #10484 among its holdings. This is a return to the name: Jane Street previously reported a position in RNAC as recently as Q1 2024.

Jane Street first reported a position in RNAC in Q2 2019 and has held it in 16 quarters since. The position peaked at $478K in Q2 2020. 95 funds tracked by Wall St. Rank hold RNAC as of Q2 2026.

  • Jane Street held 11,824 shares of Cartesian Therapeutics worth $123K as of Q2 2026.
  • Cartesian Therapeutics was a new Jane Street position in Q2 2026.
  • Cartesian Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10484 holding.
  • Jane Street first reported a position in Cartesian Therapeutics in Q2 2019 and has held it in 16 quarters since.
  • Jane Street's Cartesian Therapeutics position peaked at $478K in Q2 2020.
  • 95 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.